|
| |
| | | 70040 | | 04.12.2025 | | Novartis Pharma Schweiz AG | | | | | | | 03.12.2030 | | | | | | 70000. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Ilaris 150 mg/ml | Injektionslösung in einem Fertigpen | Injektionslösung in einem Fertigpen (Canakinumabum 150 mg/ml) | L04AC08 | CI |
|
|
|